![John D. Shaughnessy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John D.
Shaughnessy is the founder of Signal Genetics, Inc. which was founded in 2010.
He is currently the Director-Myeloma Institute for Research & Therapy at the University of Arkansas for Medical Sciences.
Dr. Shaughnessy holds a doctorate degree from the University of Maryland.
| Sociétés | Poste | Début |
|---|---|---|
University of Arkansas for Medical Sciences
 University of Arkansas for Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Signal Genetics, Inc.
 Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Provides predictive genetic testing for oncology | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arkansas for Medical Sciences
University of Arkansas for Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Signal Genetics, Inc.
Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Provides predictive genetic testing for oncology | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
